With the worst global health crisis of our lifetime showing no signs of slowing, the massive $11.9 trillion health care industry is undergoing a massive revolution.(1)
The very same opportunity that sent shares of Teladoc Health from approximately $10 to approximately $253 in less than four years.
All thanks to the rise of telehealth – a high-tech shift into the world of virtual healthcare.
With the global health crisis only getting worse, telehealth has exploded.
In fact, U.S. doctors are on track to log more than a billion visits by the end of this year alone.(3)
However, they could see far more than that.
A recent poll says approximately 76% of consumers say they’re moderately or highly interested in using telehealth as compared to 11% in 2019, according to McKinsey & Co.(4)
After all, with telehealth:
And it’s BIG BUSINESS.
So much so, analysts at Frost & Sullivan say the industry could grow sevenfold by 2025 – a five-year compound growth rate of 38.2%.(5)
“The critical need for social distancing among physicians and patients will drive unprecedented demand for telehealth, which involves the use of communication systems and networks to enable either a synchronous or asynchronous session between the patient and provider,” said Victor Camlek, healthcare principal analyst at Frost & Sullivan.(6)
Even more impressive…big investments are just beginning to flood into the sector.
One company that’s seen monster growth to date is Teladoc Health, whose stock exploded from approximately $60 to approximately $253 a share in the last year.
That’s an increase of about 322% in less than a year.
Or take a look at 1Life Healthcare Inc., whose stock ran from approximately $15 to approximately $43 a share just this year.
While these are impressive increases to date, there are other, far more inexpensive opportunities out there, just now benefiting from a potential $250 billion market boom.
One of the top telehealth stocks to be well aware of could be the next big winner in the space
We’ve uncovered a pure-play telehealth stock that’s severely undervalued as compared to Teladoc Health and. WELL Health Technologies…
At just $1.65 a share, it’s already showing signs of big growth.
In the first quarter of 2020, revenue rocketed 178% year over year to nearly $3.1 million.(7)
By the second quarter of 2020, revenue was up 163% year over year to $2.8 million with gross margins of 42%. Better yet, out of the gate, it’s network includes 14 clinics, 64 physicians, 35 specialists and allied health professionals servicing nearly 500,000 patients(8)
Better still, if you take a look at WELL Health Technologies and Teladoc Health, investors can clearly see what’s possible, as telehealth companies expand in Canada and throughout the U.S.
Far more impressive — One of the key differences CloudMD has over some of its competitors is that the Company provides such tools to the market on BOTH the consumer (B2C) and enterprise (B2B) sides of the industry, so it’s a win-win for everyone.
Plus, CloudMD is focused on rapidly increasing its patient base by onboarding clinics, increasing its physician network, direct-to-consumer advertising and through new telemedicine kiosk partnerships with high traffic pharmacies. All of these tools are ultimately building a virtual healthcare practice, continuity of care and patient centric practices.
Livecare Connect, which is a telemedicine platform used by physicians across North America, including a strategic partnership in the United States.
In addition, Livecare has been added to preferred vendor lists of leading Government associations across Canada which represent over 20,000 practitioners.
The platform also offers:
But this is just the beginning of a much bigger story.
In short, with a once in a lifetime healthcare boom, investors are being handed a potential goldmine, and severely undervalued opportunity with CloudMD.
As volatile as 2020 has been, Teladoc Health has increased approximately 142% year to date.
Year to date, 1Life Healthcare has increased approximately 61%. WELL Health Technologies has increased approximately 316%. Those are some big wins in a relatively short period of time.
But it comes as no surprise.
This can quickly happen to a stock caught in a QUARTER TRILLION DOLLAR telehealth boom.
That’s especially true as it builds a sizable footprint in North America.
In fact, since acquiring Livecare in early 2020, CloudMD has been added to the approved vendor lists with some of the biggest healthcare providers in Canada including:(11)
Together, these organizations represent approximately 20,000+ practitioners.(12)
In addition, CloudMD has seen dramatic growth, with 3600 practitioners now using the platform and almost 3 million patient charts.
That’s just in Canada.
With that IDYA4 will resell CloudMD’s Livecare technology to U.S. clients, quickly expanding services throughout the North American market.
Plus, with an extensive, established client network, IDY4A could add big value to CloudMD expansion plans. IDY4A’s client list includes:
In August 2020, the company announced its acquisition of a profitable seven location rehabilitation clinic network with $5.8 million in annual revenue.
CloudMD also signed an agreement to acquire majority interest in West Mississauga Medical Clinic, which is already cash flow positive with revenue of $1.8 million.
It also recently announced its intent to acquire a U.S. based chronic care medical clinic to capitalize a massive multi-trillion-dollar chronic mental health disease market. According to the CDC, 90% of the US $3.5 trillion spent annually on healthcare is spent on people with chronic mental health diseases.(13)
And it acquired the South Surrey Medical Clinic, which services approximately 60,000 patients and already uses online booking, EMR software and telemedicine that will be easily integrated into CloudMD’s software and clinic network.
In July 2020, CloudMD USA (DOCRF) CA (DOC) also announced it’s intent to acquire of Snapclarity Inc., an enterprise mental heal platform that will allow the company to expand into mental wellness, too.
“The COVID-19 pandemic is the most serious public health emergency of our lifetime and it has further deepened the mental health crisis we were already facing,” said Dr. Essam Hamza, CEO of CloudMD. Recent data tells us that over 56% of Canadians said the pandemic is having a negative impact on their mental health, with social isolation being the top contributing factor. This acquisition of Snapclarity is a transformational addition to CloudMD as we continue to strengthen our suite of virtual care solutions and make it easier for Canadians to get help from home. As a primary care physician for the past 20 years the importance of providing a viable tool for the mental health crisis is a deeply personal motivation for me.”(14)
Helping a bit more, the telepsychiatry market is estimated to be valued at approximately $36.3 billion by 2027.(15)
“According to the National Institute of Mental Health, in 2018 one in five adults in U.S. had a mental illness. There has been a significant rise in telemental health visits over the past decade in the developed countries such as U.S., U.K., Germany, and Spain and the trend is expected to continue during the forecast period, thereby contributing to the adoption of virtual mental health consultation by hospitals and healthcare settings.”(15)
Dr. Essam Hamza, MD – Chief Executive Officer
Dr. Hamza completed his MD and Family Practice degree at the University of Alberta in 1999. He founded HealthVue in 2005 and grew the business to include four interconnected high-tech clinics serving over 100,000 patients. He also has extensive capital markets experience, taking private companies public and sitting on public company boards.
Dr. Amit Mathur, OD – President
Dr. Amit Mathur has nearly 20 years of health experience as an optometrist and entrepreneur. He cofounded Omni & Vision, a multi-location eye care clinic group and has been a consultant- lecturer to several pharma companies and participated on their Advisory panels. He also cofounded Livecare, a pioneer company in Telehealth.
Dr. David Ostrow, MD, BSc., MA, FRCPC – Chief Medical Officer
Dr. David Ostrow was President and CEO of Vancouver Coastal Health and previously held progressively senior roles at VGH and Fraser Health. He currently is an Emeritus Professor of Medicine at UBC. He was the founding Medical Director of the BC Transplant Society/VGH’s Lung Transplant Program and was active in the founding of the Pulmonary Hypertension Clinic. He is the author/co-author of over 90 publications and continues to consult on matters of health policy & economics, technology and genomics.
Dr. Sohal Goyal – Director, Corporate Development
Dr. Sohal Goyal is a respected healthcare thought leader in Ontario and over his 18-year career has established a vast network of healthcare relationships. Dr. Goyal graduated from the University of Toronto Faculty of Medicine and is a Fellow of the College of Family Physicians. He is an assistant clinical professor with McMaster University Department of Family Medicine and is currently the Lead Physician of one of the largest Family Health Groups, which includes over 130 physicians. Dr. Goyal has held numerous leadership roles with the Ontario Medical Association and is currently chair of both District 5 and the local Primary Care Network. In addition, he has acted as an advisor for many public and private companies.
This website / media webpage is owned, operated and edited by TD Media LLC. Any wording found on this website / media webpage or disclaimer referencing to “I” or “we” or “our” or “TD Media” refers to TD Media LLC. This website / media webpage is a paid advertisement, not a recommendation nor an offer to buy or sell securities. Our business model is to be financially compensated to market and promote small public companies. By reading our website / media webpage you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis for making investment decisions and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our website / media webpage.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website / media webpage are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our website / media webpage may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. TD Media business model is to receive financial compensation to promote public companies. To conduct investor relations advertising, marketing and publicly disseminate information not limited to our Websites, Email, SMS, Push Notifications, Influencers, Social Media Postings, Ticker Tags, Press Releases, Online Interviews, Podcasts, Videos, Audio Ads, Banner Ads, Native Ads, Responsive Ads. This compensation is a major conflict of interest in our ability to be unbiased regarding. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. Our emails may contain forward-looking statements, which are not guaranteed to materialize due to a variety of factors
We do not guarantee the timeliness, accuracy, or completeness of the information on our website / media webpage. The information in our website / media webpage is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, TD Media often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
Pursuant to an agreement between TD Media LLC and Winning Media LLC, TD Media LLC has been hired for a period beginning on 6/18/20 and ending on 7/30/20 to publicly disseminate information about (DOCRF)(DOC) via digital communications. We have been paid seventy four thousand USD via bank wire transfer. We own zero shares of (DOCRF)(DOC). Pursuant to an agreement between TD Media LLC and Winning Media LLC, TD Media LLC has been hired for a period beginning on 8/10/20 and ending on 8/21/20 to publicly disseminate information about (DOCRF)(DOC) via digital communications. We have been paid an additional forty seven thousand USD via bank wire transfer. We own zero shares of (DOCRF)(DOC). To date we have been paid one hundred twenty one thousand dollars USD via bank wire transfer to disseminate information about (DOCRF)(DOC) via digital communications. Pursuant to an agreement between TD Media LLC and Winning Media LLC, TD Media LLC has been hired for a period beginning on 9/14/20 and ending on 10/9/20 to publicly disseminate information about (DOCRF)(DOC) via digital communications. We have been paid an additional one hundred fourteen thousand USD via bank wire transfer. We own zero shares of (DOCRF)(DOC). To date we have been paid two hundred thirty five thousand dollars USD via bank wire transfer to disseminate information about (DOCRF)(DOC) via digital communications. Pursuant to an agreement between TD Media LLC and Winning Media LLC, TD Media LLC has been hired for a period beginning on 10/12/20 and ending on 11/6/20 to publicly disseminate information about (DOCRF)(DOC) via digital communications. We have been paid an additional seventy five thousand USD via bank wire transfer. We own zero shares of (DOCRF)(DOC). To date we have been paid three hundred ten thousand dollars USD via bank wire transfer to disseminate information about (DOCRF)(DOC) via digital communications.